• Dépistage, diagnostic, pronostic

  • Essais de technologies et de biomarqueurs dans un contexte clinique

Expired-Air Carbon Monoxide as a predictor of 16-year risk of all-cause, cardiovascular and cancer mortality

Menée en France auprès de 2 232 participants (âge : 35 à 64 ans ; durée de suivi : 16 ans), cette étude évalue l'association entre la quantité de monoxyde de carbone expirée et le risque de décès par cancer, maladie cardiovasculaire ou autres causes

Background : Measurement of Expired-Air Carbon Monoxide (EACO) is commonly used to ascertain non-smoking status, although it can also reflect exposures not related to smoking. Our aim was to assess 16-year mortality according to EACO measured at baseline, in a general population.

Methods : Our analysis was based on the Third French MONICA population survey (1994-1997). Causes of death were obtained 16 years after inclusion, and assessment of determinants of mortality was based on Cox modelling.

Results : EACO was measured in 2232 apparently healthy participants aged 35-64. During follow-up, 195 deaths occurred (19% were due to Cardio-Vascular (CV) causes and 49% to cancer). At baseline, mean EACO was 11.8(± 7.4) ppm, 4.6(± 2.5) ppm, 4.3(± 2.2) ppm for current, former and never smokers, respectively (p<0.001). After adjustment for main mortality risk factors and smoking, the hazard ratio (HR) for total mortality was 1.03[95% confidence interval: 1.01-1.06] per 1-unit increase in EACO, and it was 1.04[1.01-1.07] for cancer mortality. Adjusted HR for CV mortality was 1.05[1.01-1.10] but did not remain significant after additional adjustment for smoking (0.98[0.91-1.04]). Interactions between EACO and smoking were not significant.

Conclusions : In a general population, baseline EACO is an independent predictor of 16-year all-cause and cancer mortality, after adjustment for confounders including smoking. Given that the effect of EACO is similar among smokers and non-smokers, EACO is probably not solely related to smoking but could also be a marker of inhaled ambient carbon monoxide and/or endogenous production. Besides, smoking better predicts CV mortality than EACO.

Preventive Medicine , résumé, 2014

Voir le bulletin